Apolipoprotein E element 4 association with dementia in a population-based study: The Framingham Study

Cited by (346)

Items 101–200 of 346

1. The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease
   Aaron J. Trachtenberg, Nicola Filippini, Jane Cheeseman, Eugene Paul Duff, Matt J. Neville, Klaus P. Ebmeier, Fredrik Karpe, Clare E. Mackay · 2011 · Neurobiology of Aging
2. Metabolic Syndrome and Amnestic Mild Cognitive Impairment: Singapore Longitudinal Ageing Study-2 Findings
   Liang Feng, Mei Sian Chong, Wee Shiong Lim, Tih-Shih W. Lee, Simon L. Collinson, Philip Lin Kiat Yap, Tze Pin Ng · 2013 · Journal of Alzheimer s Disease
3. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer’s disease
   Wang, J.C., Kwon, J.M., Shah, P., Morris, J.C., Goate, A. · 2000 · Neurology
4. The APOE ɛ4 allele affects complexity and functional connectivity of resting brain activity in healthy adults
   Albert C. Yang, Chu‐Chung Huang, Mu‐En Liu, Yin-Jay Liou, Chen‐Jee Hong, Men‐Tzung Lo, Norden Eh Huang, Chung‐Kang Peng, Ching‐Po Lin, Shih‐Jen Tsai · 2013 · Human Brain Mapping
5. The Effect of APOE-ε4 on Dementia is Mediated by Alzheimer Neuropathology
   James A. Mortimer, David A. Snowdon, William R. Markesbery · 2009 · Alzheimer Disease & Associated Disorders
6. The debate on ethnicity and dementia: from category fallacy to person-centred care?
   Steve Iliffe, Jill Manthorpe · 2004 · Aging & Mental Health
7. Mind the gaps: What we don't know about cognitive impairment in essential tremor
   Elan D. Louis, Jillian L. Joyce, Stephanie Cosentino · 2019 · Parkinsonism & Related Disorders
8. Apolipoprotein eϵ4, other risk factors, and course of alzheimer’s disease
   Myron Weiner, Gloria Vega, Richard C. Risser, Lawrence S. Honig, C. Munro Cullum, David Crumpacker, Roger N. Rosenberg · 1999 · Biological Psychiatry
9. How to Use an Article About Genetic Association: C: What Are the Results and Will They Help Me in Caring for My Patients?
   Attia, John, Ioannidis, John P. A., Thakkinstian, Ammarin, McEvoy, Mark, Scott, Rodney J., Minelli, Cosetta, Thompson, John, Infante-Rivard, Claire, Guyatt, Gordon · 2009 · JAMA
10. Heritability of plasma amyloid β in typical late‐onset Alzheimer’s disease pedigrees
    Nilüfer Ertekin‐Taner, Neill R. Graff‐Radford, Linda H. Younkin, Christopher B. Eckman, Jennifer L. Adamson, Daniel J. Schaid, John Blangero, Michael L. Hutton, Steven G. Younkin · 2001 · Genetic Epidemiology
11. ApoE genotype in relation to AD and cholesterol
    H.C. Liu, C.J. Hong, S. J. Wang, Jong‐Ling Fuh, PEI‐JIN WANG, Hann-Yeh Shyu, Evelyn Lee Teng · 1999 · Neurology
12. Apolipoprotein E Genotypes and the Incidence of Alzheimer's Disease among Persons Aged 75 Years and Older: Variation by Use of Antihypertensive Medication?
    Zhenchao Guo, Laura Fratiglioni, Matti H. Viitanen, Lars Lannfelt, Hans Basun, Johan Fastbom, Bengt G. Winblad · 2001 · American Journal of Epidemiology
13. Age, Gender, and Cancer but Not Neurodegenerative and Cardiovascular Diseases Strongly Modulate Systemic Effect of the Apolipoprotein E4 Allele on Lifespan
    Kulminski, Alexander M., Arbeev, Konstantin G., Culminskaya, Irina, Arbeeva, Liubov, Ukraintseva, Svetlana V., Stallard, Eric, Christensen, Kaare, Schupf, Nicole, Province, Michael A., Yashin, Anatoli I. · 2014 · PLoS Genetics
14. Associations between APOE genotype and cerebral small-vessel disease: a longitudinal study
    Xiao Luo, Alzheimer’s Disease Neuroimaging Initiative, Yeerfan Jiaerken, Xinfeng Yu, Peiyu Huang, Tiantian Qiu, Yunlu Jia, Kaicheng Li, Xiaojun Xu, Zhujing Shen et al. · 2017 · Oncotarget
15. The relationship between apolipoprotein E, dementia, and vascular illness
    Deborah B. Marin, Brenda Breuer, Michael L. Marin, Jeremy M. Silverman, James Schmeidler, David A. Greenberg, Sean P. Flynn, Marlene Mare, Melinda Lantz, Leslie S. Libow et al. · 1998 · Atherosclerosis
16. Risk Factors, Lifestyle Behaviors, and Vascular Brain Health
    Rebecca F. Gottesman, Sudha S. Seshadri · 2022 · Stroke
17. Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
    Adam D. Kline · 2012 · Alzheimer s Research & Therapy
18. Working Memory in Alzheimer’s Disease and Parkinson’s Disease
    Nahid Zokaei, Masud Husain · 2019 · Current topics in behavioral neurosciences
19. Apo E variants in patients with type III hyperlipoproteinemia
    Civeira, Fernando, Pocoví, Miguel, Cenarro, Ana, Casao, Elena, Vilella, Elisabet, Joven, Jordi, González, José, Garcia-Otín, Angel L., Ordovás, JoséM. · 1996 · Atherosclerosis
20. Joint effect of stroke and APOE 4 on dementia risk
    Ya-Ping Jin, Truls Østbye, John Feightner, Silvia Di Legge, Vladimir Hachinski · 2007 · Neurology
21. Spoken language biomarkers for detecting cognitive impairment
    Tuka Alhanai, Rhoda Au, James Robert Glass · 2017 · IEEE Workshop on Automatic Speech Recognition and Understanding (ASRU)
22. Genetic Analysis of Vascular Factors in Alzheimer's Disease
    Yosuke Wakutani, Hisanori Kowa, Masayoshi Kusumi, KAORU YAMAGATA, Kenji Wada‐Isoe, Yoshiki Adachi, Takao Takeshima, Katsuya Urakami, Kenji Nakashima · 2002 · Annals of the New York Academy of Sciences
23. Recent Advances in the Genetics of Alzheimer's Disease
    Ephrat Levy‐Lahad, Debby W. Tsuang, Thomas D. Bird · 1998 · Journal of Geriatric Psychiatry and Neurology
24. Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4.
    V S Rao, L. Adrienne Cupples, Cornelia M. van Duijn, Alexander Kurz, Robert C. Green, Helena Chang Chui, Ranjan Duara, Sanford H. Auerbach, Ladislav Volicer, J Wells et al. · 1996 · PubMed Central
25. The role of lipid‐related genes, aging‐related processes, and environment in healthspan
    Alexander M. Kulminski, Irina V. Culminskaya, Konstantin G. Arbeev, Svetlana V. Ukraintseva, Eric Stallard, Liubov S Arbeeva, Anatoli I. Yashin · 2013 · Aging Cell
26. APOE 4 and Hip Fracture Risk in a Community‐Based Study of Older Adults
    Janet M. Johnston, Jane A. Cauley, Mary Ganguli · 1999 · Journal of the American Geriatrics Society
27. Executive function asymmetry in older adults genetically at-risk for Alzheimer's disease: Verbal versus design fluency
    Wes S. Houston, Dean C. Delis, Amy E. Lansing, Mark W. Jacobson, Krystal Cobell, David P. Salmon, Mark William Bondi · 2005 · Journal of the International Neuropsychological Society
28. A Mathematical Model of Alzheimer's Disease and the Apoe Gene
    Angus S. Macdonald, Delme Pritchard · 2000 · Astin Bulletin
29. Apolipoprotein E4 (ApoE4) but not ApoE3 or ApoE2 potentiates β-amyloid protein activation of complement in vitro
    Patrick L. McGeer, Douglas G. Walker, Robert E. Pitas, Robert W. Mahley, Edith G. McGeer · 1997 · Brain Research
30. Do statins prevent Alzheimer's disease? A narrative review
    Daneschvar, Homayoun L., Aronson, Mark D., Smetana, Gerald W. · 2015 · European Journal of Internal Medicine
31. The Utility of Apolipoprotein E Genotyping in the Diagnosis of Alzheimer Disease in a Community-Based Case Series
    Tsuang, Debby, Larson, Eric B., Bowen, James, McCormick, Wayne, Teri, Linda, Nochlin, David, Leverenz, James B., Peskind, Elaine R., Lim, Alfredo, Raskind, Murray A. et al. · 1999 · Archives of Neurology
32. An apolipoprotein E4 fragment can promote intracellular accumulation of amyloid peptide beta 42
    Dafnis, Ioannis, Stratikos, Efstratios, Tzinia, Athina, Tsilibary, Effie C., Zannis, Vassilis I., Chroni, Angeliki · 2010 · Journal of Neurochemistry
33. Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife
    Nahid Zokaei, Kathrin Giehl, Annie Sillence, Matt J. Neville, Fredrik Karpe, Anna Christina Nobre, Masud Husain · 2016 · Cortex
34. The prevalence of apoE-epsilon 4 in Alzheimer's disease is age dependent
    Giovanni Battista Frisoni, M. Manfredi, Cristina Geroldi, Giuliano Gb. Binetti, Orazio Oz. Zanetti, Angelo Bianchetti, Marco Trabucchi · 1998 · Journal of Neurology Neurosurgery & Psychiatry
35. Apolipoprotein E Gene Polymorphism in Indian Patients with Alzheimer’s Disease and Vascular Dementia
    Kalpana Luthra, Manjari Tripathi, Rahul Grover, Manjari Dwivedi, Amit Kumar, A.B. Dey · 2004 · Dementia and Geriatric Cognitive Disorders
36. Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease
    Gyungah Jun, Yang You, Congcong Zhu, Gaoyuan Meng, Jaeyoon Chung, Rebecca Panitch, Junming Hu, Weiming Xia, David Alan Bennett, Tatiana Foroud et al. · 2022 · Alzheimer s & Dementia
37. Lack of independent associations of apolipoprotein E promoter and intron 1 polymorphisms with Alzheimer's disease
    George William Rebeck, Bonnie S. Cheung, Whitfield B. Growdon, Amy Deng, Praveen Akuthota, Joseph J. Locascio, Steven Mark Greenberg, Bradley T. Hyman · 1999 · Neuroscience Letters
38. Poststroke Dementia in the Elderly
    Marie‐Anne Mackowiak‐Cordoliani, St phanie Bombois, Armelle Mémin, Hilde H�non, Florence Pasquier · 2005 · Drugs & Aging
39. Generation of a Recombinant Apolipoprotein E Variant with Improved Biological Functions
    Kyriakos E. Kypreos, Ko Willems van Dijk, Louis M. Havekes, Vassilis I. Zannis · 2004 · Journal of Biological Chemistry
40. Interactive Effects of Apolipoprotein E Type 4 Genotype and Cerebrovascular Risk on Neuropsychological Performance and Structural Brain Changes
    David D. Zade, Alexa Beiser, Regina E. McGlinchey, Rhoda Au, Sudha S. Seshadri, Carole L. Palumbo, Philip A. Wolf, Charles S DeCarli, William Milberg · 2010 · Journal of Stroke and Cerebrovascular Diseases
41. Cognitive Impairment
    Seema Joshi, John Edward Morley · 2006 · Medical Clinics of North America
42. Apolipoprotein E Genotype and Lipid and Lipoprotein Levels in Dementia
    Hanna Wehr, Tadeusz Parnowski, S Puźyński, Małgorzata Bednarska‐Makaruk, Mariola Bisko, Sławomira Kotapka-Minc, MARIA RODO, M. Wołkowska · 2000 · Dementia and Geriatric Cognitive Disorders
43. ERβ and ApoE isoforms interact to regulate BDNF–5-HT2A signaling and synaptic function in the female brain
    Anindit Chhibber, Liqin Zhao · 2017 · Alzheimer s Research & Therapy
44. Tau‐associated neuropathology in ganglion cell tumours increases with patient age but appears unrelated to ApoE genotype
    Daniel Jay Brat, Marla Gearing, Patricia T. Goldthwaite, Bruce H. Wainer, Peter C. Burger · 2001 · Neuropathology and Applied Neurobiology
45. Clinical evaluation: a systematic but user-friendly approach
    Oscar L. López, David A. Wolk · 2009 · Cambridge University Press eBooks
46. APOE epsilon-4 allele and cytokine production in Alzheimer's disease
    Olgiati, Paolo, Politis, Antonis, Malitas, Petros, Albani, Diego, Dusi, Sabrina, Polito, Letizia, De Mauro, Stefania, Zisaki, Aikaterini, Piperi, Christina, Stamouli, Evangelia et al. · 2010 · International Journal of Geriatric Psychiatry
47. Apolipoprotein E and Alzheimer's disease: a genetic, molecular and neuroimaging review.
    Richard H. Swartz, Sandra E. Black, Peter St George‐Hyslop · 1999 · PubMed
48. Dementia Entanglements in a Postgenomic Era
    Margaret M. Lock · 2010 · Science Technology & Human Values
49. Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population
    Janos L. Kalman, Anna Juhász, Albert Császár, Andor Kanka, Ágnes Rimanóczy, Z. Janka, István Raskó · 1998 · Acta Neurologica Scandinavica
50. Gene expression levels as endophenotypes in genome-wide association studies of Alzheimer disease
    F. Zou, Minerva M. Carrasquillo, V. Shane Pankratz, Olivia Belbin, Kevin Morgan, Mariet Allen, Samantha L. Wilcox, Li Ma, Louise P. Walker, Naomi Kouri et al. · 2010 · Neurology
51. Apolipoprotein Ε ε4 Frequency Is Increased among Chinese Patients with Frontotemporal Dementia and Alzheimer's Disease
    Yong Ji, Mengyuan Liu, Ya Ruth Huo, Shuling Liu, Zhihong Shi, Shuai Liu, Thomas Wısnıewskı, Jinhuan Wang · 2013 · Dementia and Geriatric Cognitive Disorders
52. APOE genotype in cerebrovascular disease and vascular dementia
    Ana Frank, Exuperio Díez‐Tejedor, Maria Jesus Bullido, Fernando Valdivieso, Pablo Barreiro · 2002 · Journal of the Neurological Sciences
53. Lack of Association Between Apolipoprotein E Polymorphism and Vascular Dementia in Koreans
    Ki Woong Kim, JongChul Youn, Moon‐Ku Han, Nam‐Jong Paik, Tae Joo Lee, Joon Hyuk Park, Seok Bum Lee, Il Han Choo, Dong Young Lee, Jin Hyeong Jhoo et al. · 2008 · Journal of Geriatric Psychiatry and Neurology
54. Altered functional connectivity of the default mode and dorsal attention network in subjective cognitive decline
    Deokjong Lee, Jin Young Park, Woo Jung Kim · 2023 · Journal of Psychiatric Research
55. Competitive ELISA studies of neural thread protein in urine in Alzheimer's disease
    Susanna Levy, Matthew McConville, Glorie A. Lazaro, Paul Averback · 2007 · Journal of Clinical Laboratory Analysis
56. An apolipoprotein E4 fragment affects matrix metalloproteinase 9, tissue inhibitor of metalloproteinase 1 and cytokine levels in brain cell lines
    Dafnis, I., Tzinia, A.K., Tsilibary, E.C., Zannis, V.I., Chroni, A. · 2012 · Neuroscience
57. How to Use an Article About Genetic Association
    John Attia, John P. A. Ioannidis, Ammarin Thakkinstian, Mark McEvoy, Rodney J. Scott, Cosetta Minelli, John Russell Thompson, Claire Infante‐Rivard, Gordon Henry Guyatt · 2009
58. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment
    Sanford I. Finkel, J. Costa E. Silva, Gillian Cohen, S. Miller, Norman Sartorius · 1997 · International Journal of Geriatric Psychiatry
59. Protection against Alzheimer's disease?
    Alistair S. Burns, Declan Murphy · 1996 · The Lancet
60. Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4
    Argyri, Letta, Dafnis, Ioannis, Theodossiou, Theodossis A., Gantz, Donald, Stratikos, Efstratios, Chroni, Angeliki · 2014 · Journal of Biological Chemistry
61. A combined effect of two Alzheimer's risk genes on medial temporal activity during executive attention in young adults
    Adam E. Green, Jeremy R. Gray, Colin G. DeYoung, Timothy R. Mhyre, Robert M. Padilla, Amanda Marie DiBattista, George William Rebeck · 2014 · Neuropsychologia
62. Survival in Finnish Centenarians in Relation to Apolipoprotein E Polymorphism
    Jukka Louhija, Matti H. Viitanen, Hedda Agüero‐Torres, Reijo S. Tilvis · 2001 · Journal of the American Geriatrics Society
63. Single Photon Emission Computed Tomography and Apolipoprotein E in Alzheimer's Disease: Impact of the ε4 Allele on Regional Cerebral Blood Flow
    Peter Høgh, Gitte M. Knudsen, Karen Husted-Kjaer, Ole Steen Jørgensen, Olaf Bjarne Paulson, Gunhild Waldemar · 2001 · Journal of Geriatric Psychiatry and Neurology
64. Relation of plasma β‐amyloid, clusterin, and tau with cerebral microbleeds: Framingham Heart Study
    Jose Rafael Romero, Serkalem Demissie, Alexa Beiser, Jayandra Jung Himali, Charles S DeCarli, Daniel A Levy, Sudha S. Seshadri · 2020 · Annals of Clinical and Translational Neurology
65. Antibodies to Potato Virus Y Bind the Amyloid β Peptide
    Robert Paul Friedland, Johnathan M. Tedesco, Andrea C. Wilson, Craig Atwood, Mark A. Smith, George L. Perry, Michael G. Zagorski · 2008 · Journal of Biological Chemistry
66. Altered expression of insulin‐degrading enzyme and regulator of calcineurin in the rat intracerebral streptozotocin model and human apolipoprotein E‐ε4–associated Alzheimer's disease
    Büşra Delikkaya, Natalia Moriel, Ming Tong, Gina M. Gallucci, Suzanne M. de la Monte · 2019 · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring
67. C‐Reactive Protein Mediates the Effect of Apolipoprotein E on Cytomegalovirus Infection
    Allison E. Aiello, Hoang‐Oanh T. Nguyen, Mary N. Haan · 2007 · The Journal of Infectious Diseases
68. Dissociable effects of the apolipoprotein-E (APOE) gene on short- and long-term memories
    Nahid Zokaei, Giedrė Čepukaitytė, Alexander Board, Clare E. Mackay, Masud Husain, Anna Christina Nobre · 2018 · Neurobiology of Aging
69. Antihypertensives for combating dementia? A perspective on candidate molecular mechanisms and population-based prevention
    Michael Valenzuela, Murray Esler, Karen A. Ritchie, Henry Brodaty · 2012 · Translational Psychiatry
70. Trade-Off in the Effect of the APOE Gene on the Ages at Onset of Cardiocascular Disease and Cancer across Ages, Gender, and Human Generations
    Alexander M. Kulminski, Irina V. Culminskaya, Konstantin G. Arbeev, Svetlana V. Ukraintseva, Liubov S Arbeeva, Anatoli I. Yashin · 2012 · Rejuvenation Research
71. Reduced Physiological Complexity in Robust Elderly Adults with the APOE ε4 Allele
    Daniel Cheng, Shih‐Jen Tsai, Chen‐Jee Hong, Albert C. Yang · 2009 · PLoS ONE
72. Apolipoprotein E Genotypes in Hospitalized Elderly Patients with Vascular Dementia
    Giuseppe Orsitto, Davide Seripa, Francesco Panza, Marilisa Franceschi, Leandro Cascavilla, Giuliana Placentino, Maria Giovanna Matera, Francesco Paris, Cristiano A. Capurso, Vincenzo Solfrizzi et al. · 2007 · Dementia and Geriatric Cognitive Disorders
73. Genetic testing for Alzheimer's disease
    Peter K. Panegyres, Carmela Pestell, Toni Liebeck, Jack Goldblatt, Ian Walpole, Karen Harrop · 2000 · The Medical Journal of Australia
74. Role of Apolipoprotein E in Alzheimer’s Disease
    Vassilis I. Zannis, Eleni E. Zanni, Savvas C. Makrides, Dimitris Kardassis, Sergei B. Aleshkov · 1998 · Springer eBooks
75. Mechanistic insight into the capacity of natural polar phenolic compounds to abolish Alzheimer's disease-associated pathogenic effects of apoE4 forms
    Christina Mountaki, Ioannis Dafnis, Eirini A. Panagopoulou, Paraskevi B. Vasilakopoulou, Michalis Karvelas, Antonia Chiou, Vaios Τ. Karathanos, Angeliki Chroni · 2021 · Free Radical Biology and Medicine
76. Apolipoprotein E type ε4 allele, heritability and age at onset in twins with Alzheimer disease and vascular dementia
    Astrid Liv Mina Bergem, Lars Lannfelt · 1997 · Clinical Genetics
77. Biological markers of aging and mental health: A seed and soil model of neurocognitive disorders
    Ian M. McDonough, Rebecca S. Allen · 2018 · Aging & Mental Health
78. Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality
    Alexander M. Kulminski, Liang He, Irina V. Culminskaya, Yury Loika, Yelena Kernogitski, Konstantin G. Arbeev, Elena Loiko, Liubov S Arbeeva, Olivia Bagley, Matt Duan et al. · 2016 · PLoS Genetics
79. The apolipoprotein E ?4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities
    Peter Høgh, Ellen Garde, Erik Lykke Mortensen, O. S. Jørgensen, K. S. Krabbe, Gunhild Waldemar · 2007 · Acta Neurologica Scandinavica
80. Functional connectivity of the hippocampus in elderly with mild memory dysfunction carrying the APOE ɛ4 allele
    David Bartrés‐Faz, Josep Maria Serra-Grabulosa, Felice T. Sun, Cristina Solé‐Padullés, Lorena Rami, José Luís Molinuevo, Beatríz Bosch, Josep M. Mercader, Núria Bargalló, Carles Falcón et al. · 2007 · Neurobiology of Aging
81. Genotypes and Phenotypes for Apolipoprotein E and Alzheimer Disease in the Honolulu-Asia Aging Study
    Jan W. P. F. Kardaun, Lon R. White, Helaine E. Resnick, Helen Petrovitch, Santica M. Marcovina, Ann M. Saunders, Dan Foley, Richard J. Havlik · 2000 · Clinical Chemistry
82. Risk of Left Ventricular Dysfunction in Patients with Probable Alzheimer's Disease with APOE*4 Allele
    Tischa J. M. van der Cammen, C.J. Verschoor, C. P. M. van Loon, F. van Harskamp, Inge de Koning, Willem J. Schudel, Arjen J. C. Slooter, Christine Van Broeckhoven, Cornelia M. van Duijn · 1998 · Journal of the American Geriatrics Society
83. Education and Cardiovascular Health as Effect Modifiers of APOE ε4 on Dementia: The Atherosclerosis Risk in Communities Study
    Mark Lee, Timothy M. Hughes, Kristen M. George, Michael E Griswold, Sanaz Sedaghat, Jeannette M Simino, Pamela L. Lutsey · 2021 · The Journals of Gerontology Series A
84. Apolipoprotein E Polymorphism and Age at Onset of Alzheimer’s Disease in a Quadriethnic Sample
    Oh Dae Kwon, Aisha Khaleeq, Wenyaw Chan, Valory Pavlik, Rachelle Smith Doody · 2010 · Dementia and Geriatric Cognitive Disorders
85. Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer’s Disease Patients
    Dinkel, Felix, Trujillo-Rodriguez, Diana, Villegas, Andres, Streffer, Johannes, Mercken, Marc, Lopera, Francisco, Glatzel, Markus, Sepulveda-Falla, Diego · 2020 · Frontiers in Aging Neuroscience
86. Prospective Study of Risk Factors for Alzheimer’s Disease: Results at 7.5 Years
    George S. Zubenko, Ethel Winwood, Barbara Jacobs, Ivana Teply, J. Scott Stiffler, Hugh B. Hughes, F. Jacob Huff, Trey Sunderland, A. J. Martinez · 1999 · American Journal of Psychiatry
87. Prevalence of Dementia and Apolipoprotein E Genotype Distribution in the Elderly of Buttapietra, Verona Province, Italy
    Maria Donata Benedetti, Alessandro Salviati, S. Filipponi, M. Manfredi, L. De Togni, Macarena Gomez‐Lira, Gianola Stenta, Emiliana Fincati, M. Pampanin, N. Rizzuto et al. · 2002 · Neuroepidemiology
88. The epidemiology of Alzheimer’s disease and vascular dementia in Japanese and African-American populations: the search for etiological clues
    Marie‐Florence Shadlen, Eric Berg Larson, Michi Yukawa · 2000 · Neurobiology of Aging
89. The association of a cystatin C gene polymorphism with late-onset Alzheimer's disease and vascular dementia.
    Cheng‐Chieh Lin, S. T. Wang, C W Wu, Liang-Jen Chuo, Yu‐Min Kuo · 2003 · PubMed
90. The Physical Activity and Alzheimer’s Disease (PAAD) Study: Cognitive outcomes
    Jennifer L. Etnier, William B. Karper, Jeffrey D. Labban, Aaron T. Piepmeier, Chia-Hao Shih, William N. Dudley, Vincent C. Henrich, Laurie Wideman · 2018 · Annals of Behavioral Medicine
91. Lack of allelic imbalance in APOE ϵ 3/4 brain mRNA expression in Alzheimer's disease
    Whitfield B. Growdon, Bonnie S. Cheung, Bradley T. Hyman, George William Rebeck · 1999 · Neuroscience Letters
92. Examination of Candidate Exonic Variants for Association to Alzheimer Disease in the Amish
    Laura N. D’Aoust, Anna C. Cummings, Reneé A. Laux, Denise Fuzzell, Laura J. Caywood, Lori Reinhart‐Mercer, William K. Scott, Margaret Ann Pericak‐Vance, Jonathan L. Haines · 2015 · PLoS ONE
93. The Role of Cardiovascular Risk Factors in Alzheimer's Disease
    Ramit Ravona‐Springer, Michael Davidson, Shlomo Noy · 2003 · CNS Spectrums
94. Medical Anthropology and Mental Health
    Arthur Kleinman · 2012 · Duke University Press eBooks
95. Ethical Principles and Pitfalls of Genetic Testing for Dementia
    Peter Hedera · 2001 · Journal of Geriatric Psychiatry and Neurology
96. Differential susceptibity of transgenic mice lacking one or both apolipoprotein alleles to folate and vitamin E deprivation
    Thomas B. Shea, Daniela Ortiz, Eugene J. Rogers · 2004 · Journal of Alzheimer s Disease
97. Apolipoprotein E (APOE) genotype, dementia, and memory performance among Caribbean Hispanic versus US populations
    Jorge J. Llibre‐Guerra, Jing Li, Yuting Qian, Juan J. Llibre Rodríguez, Ivonne Z. Jiménez‐Velázquez, Daisy M Acosta, Aquiles Salas, Juan Carlos Llíbre-Guerra, Adolfo Valvuerdi, Amal Harrati et al. · 2022 · Alzheimer s & Dementia
98. Anthropology and the Study of Disability Worlds
    Rayna Rapp, Faye Ginsburg · 2012 · Duke University Press eBooks
99. The potential roles of genetic factors in predicting ageing-related cognitive change and Alzheimer’s disease
    Gongbu Pan, Anna Elizabeth King, Feitong Wu, Steve Simpson, Adele Woodhouse, Andrew Phipps, James Clement Vickers · 2021 · Ageing Research Reviews
100. Association Between Body Mass Index and Cognitive Function in Mild Cognitive Impairment Regardless of APOE ε4 Status
     Ye Sol Mun, Hee Kyung Park, Jihee Kim, Jiyoung Yeom, Geon Ha Kim, Min Young Chun, Hye Ah Lee, Soo Jin Yoon, Hee Kyung Park, Eun‐Joo Kim et al. · 2022 · Dementia and Neurocognitive Disorders